Granules India Secures Sole First-to-File Status for Sodium Oxybate Generic in US
Granules India has achieved Sole First-to-File status for its Sodium Oxybate Extended-Release ANDA, a generic equivalent of LUMRYZ. This regulatory milestone provides a strategic advantage in the US complex generics market and potentially grants the company marketing exclusivity.
Glenmark Pharmaceuticals Launches Lacosamide Injection in USA Targeting $15.2M Market
Glenmark Pharmaceuticals Inc., USA, has announced the commercial launch of Lacosamide Injection USP, a generic version of Vimpat®. This move expands the company's injectable portfolio in the United States, targeting a market with approximately $15.2 million in annual sales as of April 2026.
Aurionpro Solutions Bags Largest US Fintech Order Worth USD 33 Million Over Three Years
Aurionpro Solutions Ltd has announced its largest-ever US market win, a three-year fintech contract valued at USD 33 million (approximately ₹316.80 Crore). The project involves delivering advanced AI-led technology solutions and platform enhancements for a leading digital insurance payments provider.